Shares of vaccine maker Moderna (MRNA) plunged 17.9% and closed at $284.
Moderna (MRNA) has signed a strategic research and development collaboration agreement with Metagenomi, a genetic medicines company. Following the news, shares of the …
Swissmedic has authorized the booster dose of Moderna (MRNA) COVID-19 vaccine, Spikevax. The dose provided by the American pharmaceutical and biotechnology company can …
Shares of Moderna (MRNA) rose 7.05% on Monday to close at $349.
The U.S.
Shares of Moderna, Inc. (MRNA) declined 9% to close at $302.
Shares of Moderna, Inc. (MRNA) rose 1.
The South Korean government is in talks with Moderna (MRNA) and Pfizer (PFE) about manufacturing their COVID-19 vaccines in the country, according to …
Moderna, Inc. (MRNA), known for its messenger RNA (mRNA) therapeutics and vaccines, confirmed the purchase of 150 million additional COVID-19 vaccine doses by …
Moderna (MRNA) plans to increase its COVID-19 vaccine production capacity to meet the growing demand for doses, according to a Wall Street Journal …
